Dr. Rosenberg is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1800 Orleans St.
Sheikh Zayed Tower
Baltimore, MD 21287Phone+1 410-550-6337- Is this information wrong?
Summary
- Dr. Paul Rosenberg is a psychiatrist in Baltimore, MD and is affiliated with Johns Hopkins Bayview Medical Center. He received his medical degree from University of Maryland School of Medicine and has been in practice 32 years. He specializes in geriatric psychiatry and is experienced in depression, delirium, and dementa. He has > 130 peer-reviewed publications. He is currently recruiting for trials of escitalopram and THC for agitation in Alzheimer's, psilocybin for depression in mild cognitive impairment, and trazodone for sleep and cognition in mild cognitive impairment.
Education & Training
- Massachusetts General Hospital/McLean HospitalResidency, Psychiatry, 1990 - 1991
- Tufts Medical CenterResidency, Psychiatry, 1988 - 1990
- Boston University Medical CenterInternship, Internal Medicine, 1985 - 1986
- University of Maryland School of MedicineClass of 1985
- Harvard UniversityBA, Magna Cum Laude, 1979
Certifications & Licensure
- MD State Medical License 1991 - 2025
- MA State Medical License 1986 - 2005
- American Board of Psychiatry and Neurology Psychiatry
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2013
- Paul Beeson Scholar American Foundation for Aging Research, AFAR, 2008
Clinical Trials
- Trial of Dronabinol Adjunctive Treatment of Agitation in Alzheimer's Disease Start of enrollment: 2017 Mar 01
- Evaluate the Effect of Atorvastatin on Cerebrovascular Reactivity in MCI Start of enrollment: 2021 May 21
- Targeting Cognition in Early Alzheimer's Disease by Improving Sleep With Trazodone Start of enrollment: 2023 Jan 04
Roles: Contact
- Join now to see all
Publications & Presentations
PubMed
- COcerebrovascular reactivity measured with CBF-MRI in older individuals: Association with cognition, physical function, amyloid, and tau proteins.Sandeepa Sur, Zixuan Lin, Yang Li, Sevil Yasar, Paul B Rosenberg, Abhay Moghekar, Xirui Hou, Dengrong Jiang, Rita R Kalyani, Kaisha Hazel, George Pottanat, Cuimei Xu, ...> ;Journal of Cerebral Blood Flow and Metabolism. 2024 Mar 15
- Evaluating a Novel 24-Hour Rest/Activity Rhythm Marker of Preclinical β-Amyloid Deposition.Spira, A., Liu, F., Zipunnikov, V., Bilgel, M., Rabinowitz, J., An, Y., Di, J., Bai, J., Wanigatunga, S., Wu, M., Lucey, B., Schrack, J., Wanigatunga, A., Rosenberg, P...> ;Sleep. 2024 Feb 21
- Longitudinal associations of apathy and regional tau in mild cognitive impairment and dementia: Findings from the Alzheimer's Disease Neuroimaging Initiative.Pranitha Y Premnath, Joseph J Locascio, Kayden J Mimmack, Christopher Gonzalez, Michael J Properzi, Onyinye Udeogu, Paul B Rosenberg, Gad A Marshall, Jennifer R Gatchel> ;Alzheimer's & Dementia. 2024 Feb 1
- Join now to see all
Journal Articles
- Effect of Depth of Sedation in Older Patients Undergoing Hip Fracture Repair on Postoperative DeliriumThe STRIDE Randomized Clinical TrialFrederick E Sieber, Allan Gottschalk, Karin J Neufeld, Simon C Mears, Erik A Hasenboehler, Esther S Oh, Mahmood Jaberi, George E Bigelow, Paul B Rosenberg, JAMA
- Neuropsychiatric Symptoms in Alzheimer's Disease: What Might Be Associated Brain Circuits?Rosenberg PB, Nowrangi MA, Lyketsos CG, Molecular Aspects of Medicine, 1/1/2015
- Effect of Medications on Physical Function and Cognition in Nursing Home Residents with DementiaDutcher SK, Rattinger GB, Langenberg P, Chhabra PT, Liu X, Rosenberg PB, Leoutsakos JM, Simoni-Wastila L, Walker LD, Franey CS, Zuckerman IH, J Am Geriatr Soc, 1/13/2014
- Join now to see all
Books/Book Chapters
Lectures
- Primary and Secondary Prevention of Alzheimer's DiseaseBaltimore, MD - 1/27/2014
- Development of treatments for depression in Alzheimer's DiseaseBaltimore, MD - 1/8/2014
- Clinical Trial Challenges in the Study of Age-related Cognitive Disorders1/19/2013
- Join now to see all
Other
- Emerging Imaging and Therapeutics in Alzheimer's Disease: Early Detection and InterventionVideotaping for Future Webcast on Medscape Spotlight, Sponsored by Vindico Medical Education
Boston MA - 1/14/2013 - Clinical Conversations in Alzheimer's DiseaseJHU CME for Webcast
1/2/2013 - Clinical Conversations in Alzheimer's Disease: Exploring the Diagnostic and Therapeutic FrontierWebinar CME
1/1/2013
Press Mentions
- Depression Synergy with Amyloid and Increased Risk of Cognitive Decline in Preclinical Alzheimer DiseaseAugust 16th, 2019
- 8 Myths About Dementia You Shouldn’t BelieveOctober 24th, 2018
- Antidepressant Holds Promise in Treating Alzheimer's AgitationFebruary 18th, 2014
- Join now to see all
Grant Support
- Diads-3: An RCT Of Venlafaxine For Depression In ADNational Institute On Aging2011
- The Role Of STIM1 In Cardiac And Skeletal Muscle FunctionNational Heart, Lung, And Blood Institute2009–2011
- PET Imaging Of Activated Microglia In Alzheimer'S DiseaseNational Institute On Aging2008–2011
- Apathy In Alzheimer'S Disease Methylphenidate TrialNational Institute On Aging2009–2010
Hospital Affiliations
- Johns Hopkins Bayview Medical CenterBaltimore, Maryland
External Links
- Johns Hopkins Physicianshttp://www.hopkinsmedicine.org/paul-rosenberg
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: